AANEM Practice News Express

AANEM News Express

AANEM Foundation Funds Study Focused on Quality EDX

The AANEM Foundation has committed over $245,000 to a project evaluating the quality of electrodiagnostic (EDX) studies in patients with suspected carpal tunnel syndrome (CTS). “In the current environment of having to prove quality, this study is key for the future for our members,” noted Dr. Vincent Tranchitella, who spearheaded the project while serving as AANEM President in 2014-15.

Posterior Interosseous Neuropathy: Supinator Syndrome vs. Fascicular Radial Neuropathy

This study in Neurology is an excellent review of PIN syndrome and radial nerve anatomy.

Early Diaphragm Pacing in Patients with ALS (RespiStim ALS): a Randomized Controlled Triple Blind Trial

While diaphragm pacing previously held much promise as a novel treatment for ALS, this study in Lancet Neurology indicates that diaphragm pacing reduces life expectancy and is associated with serious complications.

A Comparison Between IVIg and Plasma Exchange as Preparations Before Thymectomy in Myasthenia Gravis Patients

This study in Acta Neurologica Belgica suggests that IVIg and plasma exchange may be comparable preparatory treatments for patients undergoing thymectomy.

High Risk of Cancer in Autoimmune Necrotizing Myopathies: Usefulness of Myositis Specific Antibody

This study in Brain sheds light on the relationship between necrotizing autoimmune myopathy antibody status and malignancy.

Myasthenia Gravis Treated with Autologous Hematopoietic Stem Cell Transplantation

This study in JAMA Neurology is a retrospective case series on refractory myasthenia gravis treated by hematopoietic stem cell transplantation.

Simmons Named New Muscle & Nerve Editor-In-Chief

The AANEM is pleased to announce the selection of Zachary Simmons, MD, as the new Editor-in-Chief of Muscle & Nerve, beginning with the January 2017 issue.

Clinical Characteristics of Patients with Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin

The objective of this study in JAMA Neurology of patients with myasthenia gravis was to determine the characteristics of patients negative for both acetylcholine receptor antibodies (AchR Ab) and MuSK antibodies and positive for cortactin antibodies and compare them with seropositive patients.

2017 Physician Fee Schedule Final Rule—What Does This Rule Mean for Reimbursement?

On November 2, 2016, the Center for Medicare and Medicaid Services (CMS) issued the final rule updating payment policies and payment rates for physicians under the Medicare Physician Fee Schedule (MPFS) for 2017. Following is a summary of some of the changes affecting reimbursement for AANEM members for the calendar year (CY) 2017.

MACRA Resources For Members Available

After reviewing all 2398 pages of the final MACRA rule, AANEM policy staff have worked diligently to create resources for members to help them understand the key provisions of this complex ruling and how it will affect their practices.